Author

Ernesto Aycardi

Xenon Pharmaceuticals (Canada)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alison J. CuttsiD· 1 shared Celene Grayson· 1 shared Chuck Yonan· 1 shared Constanza Luzon· 1 shared Cynthia L. Harden· 1 shared Dietrich HaubenbergeriD· 1 shared Eric JeniD· 1 shared Hillary Savoie· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Alison J. CuttsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clinical Characteristics and Treatment Experience of Individuals with SCN8A Developmental and Epileptic Encephalopathy (SCN8A-DEE): Findings from an Online Caregiver Survey

Alison J. Cutts, Hillary Savoie, Michael F. Hammer, John M. Schreiber, Celene Grayson, Constanza Luzon, Noam N. Butterfield, Simon Neil Pimstone, Ernesto Aycardi, Cynthia L. Harden, Chuck Yonan, Eric Jen, Trung Nguyen, Tara Carmack, Dietrich Haubenberger

This study surveys caregivers of SCN8A-DEE patients to describe clinical features and treatment challenges, finding high seizure burden, multiple comorbidities, and limited effective therapies.

Seizure · Mar 10, 2022Peer-reviewedGenetic & Genomic Medicine